Switzerland · Research startup
Switzerland · Centenara Labs AG
Centenara Labs AG is a clinical-stage biotechnology company based in Schlieren, Zurich, Switzerland, with operations in Barcelona, Spain.
Funding reportedLast round: Series B
About Centenara Labs AG
Centenara Labs AG is a clinical-stage biotechnology company based in Schlieren, Zurich, Switzerland, with operations in Barcelona, Spain.
Founded in 2019, the company focuses on developing therapies that target the hallmarks of aging, aiming to promote healthy aging and address age-related diseases such as cancer, fibrosis, and neurodegenerative disorders. In August 2024, the company rebranded from Rejuveron Life Sciences AG to Centenara Labs AG to reflect its evolved strategic focus. Operating under a "hub and spoke" model, Centenara Labs provides funding, mentorship, and operational support to scientific entrepreneurs and portfolio companies. The company is advancing a clinical-stage pipeline that includes therapies for retinitis pigmentosa and age-related sarcopenia, along with pre-clinical programs targeting cellular senescence and neurodegenerative diseases. Centenara Labs is dedicated to translating scientific research into innovative medicines that improve the quality of life for older adults and reduce the strain on global healthcare systems.
What company datasets say Centenara Labs AG raised
Funding, as reported
Founders and team
From Centenara Labs AG's own website: 1 founder, 3 on the team.
- Etienne BinantChief Executive Officer
- Lisa BalsigerOperations Manager
- Shannon KlingerIndependent Board Member
AdvisersMatt Kaeberlein PhDProf. Brian Kennedy PhD
On 4 portfolio pages
Investors who name them
Each firm lists Centenara Labs AG on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health caresenescent cellssenescence targetingbiotechnology researchlongevity sciencehallmarks of aging therapieshealthspan extensionhospital & health careclinical stage therapiesmedicaltelomere repairtelomere restorationhealthbiotechnologyportfolio companiesaging biology
Built with from their website
Trend Micro Email SecurityGoogle Tag ManagerpunycodeWordPress.orgTailwind CSSFont AwesomeCloudflare DNSCloudFlareViewport MetaVisual Composer
+8 more
CookieYesGoogle AnalyticsHTTP/3Cloudflare WAFGoogle Analytics 4WordpressMicrosoft Exchange OnlineApple Business Manager
- Sector
- Research
- Industry code
- NAICS 541714, SIC 2834, 8731
- Region
- Zurich
Research in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Centenara Labs AG in front of investors. Or tell us what we have wrong.